Previous 10 | Next 10 |
The following slide deck was published by 22nd Century Group, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: 22nd Century Group, Inc. 2020 Q4 - Results - Earnings Call Presentation
22nd Century (XXII): Q4 GAAP EPS of -$0.05 misses by $0.02.Revenue of $7.3M (+0.7% Y/Y) beats by $1.3M.Press Release For further details see: 22nd Century EPS misses by $0.02, beats on revenue
Key Business and Financial Highlights 22nd Century has a tremendous global commercial opportunity in the more than $800 billion markets across the tobacco and hemp/cannabis industry. Securing Modified Risk Tobacco Product (MRTP) authorization for VLN ® remains 22nd ...
WILLIAMSVILLE, N.Y., March 05, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today announced that members of its man...
Institutions & Insiders Are Buying These Penny Stocks Right Now If there’s one thing that gets traders excited about penny stocks , it’s when “big buyers” are present. But how would you know a major institution was buying shares of a company? Furtherm...
3 Penny Stocks Making Big Moves This Week Penny stocks present a low-cost option for both retail and institutional investors. Now, while they may be cheap, there is some finesse involved in finding the best stocks to buy. The first step we have to take is identifying how current eve...
Delta, Kelowna, BC - December 17, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus in...
22nd Century Group (XXII) has been on an incredible run since receiving a new U.S. patent for breakthrough technology that helps reduce nicotine in tobacco plants. Read ahead to find out if XXII can continue its momentum. The company is awaiting imminent authorization of its MRTP (Modified Ri...
Prevail Therapeutics (PRVL) +84% on being acquired by Lilly for ~$1.04B.OncoCyte Corporation (OCX) +63% after company enters agreement with Burning Rock Biotech.Anavex Life Sciences (AVXL) +40% as it's blarcamesine successful in mid-stage rett syndrome study.Mid-Con Energy Part...
Cannabis stocks are seeing catalyst movements upwards with the recent legalization of some 50% MoM; MJ ETF is not adequate in following the top stocks for cannabis; Putting together a portfolio with a tracker to follow upward movements in cannabis industry. For further detai...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...